Related references
Note: Only part of the references are listed.T-helper-1-cell cytokines drive cancer into senescence
Heidi Braumueller et al.
NATURE (2013)
Recruitment of Natural Killer Cells in Advanced Stages of Endogenously Arising B-cell Lymphoma: Implications for Therapeutic Cell Transfer
Margarethe Przewoznik et al.
JOURNAL OF IMMUNOTHERAPY (2012)
Requirements for control of B-cell lymphoma by NK cells
Christoph D. Brenner et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
EpCAM, a human tumor-associated antigen promotes Th2 development and tumor immune evasion
Alexandra Ziegler et al.
BLOOD (2009)
DC therapy induces long-term NK reactivity to tumors via host DC
Kanako Shimizu et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
TNFR1 signaling and IFN-γ signaling determine whether T cells induce tumor dormancy or promote multistage carcinogenesis
Nele Mueller-Hermelink et al.
CANCER CELL (2008)
Enhanced antitumor immunity elicited by dendritic cell vaccines is a result of their ability to engage both CTL and IFNγ-producing NK cells
Khalil Karimi et al.
MOLECULAR THERAPY (2008)
Specific targeting of whole lymphoma cells to dendritic cells ex vivo provides a potent antitumor vaccine
Christian Adam et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2007)
DC-NK cell cross talk as a novel CD4+ T-cell-independent pathway for antitumor CTL induction
C Adam et al.
BLOOD (2005)
Natural killer cells activated by MHC class Ilow targets prime dendritic cells to induce protective CD8 T cell responses
R Mocikat et al.
IMMUNITY (2003)
Dendritic cell-induced activation of adaptive and innate antitumor immunity
LT van den Broeke et al.
JOURNAL OF IMMUNOLOGY (2003)
Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells
G Ferlazzo et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Reciprocal activating interaction between natural killer cells and dendritic cells
F Gerosa et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells
D Piccioli et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo
A Cerwenka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Mast cells control neutrophil recruitment during T cell-mediated delayed-type hypersensitivity reactions through tumor necrosis factor and macrophage inflammatory protein 2
T Biedermann et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Burkitt lymphoma in the mouse
AL Kovalchuk et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Recruitment and activation of natural killer (NK) cells in vivo determined by the target cell phenotype:: An adaptive component of NK cell-mediated responses
R Glas et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)